The Glioblastoma Treatment Drugs Market is projected to generate USD 844.8 million in revenues by 2025 and is expected to reach approximately USD 1,470.5 million by 2035, expanding at a CAGR of 5.7%. The glioblastoma treatment drugs market remains one of the most active and high-need oncology spaces, driven by limited survival outcomes, high relapse …